ロード中...
The Risks and Benefits of Long-term Use of Hydroxyurea in Sickle Cell Anemia: A 17.5 Year Follow-Up
A randomized, controlled clinical trial established the efficacy and safety of short-term use of hydroxyurea in adult sickle cell anemia. To examine the risks and benefits of long-term hydroxyurea usage, patients in this trial were followed for 17.5 years during which they could start or stop hydrox...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2879711/ https://ncbi.nlm.nih.gov/pubmed/20513116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.21699 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|